Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis
托法替尼抑制1型免疫与长期结节病的显著改善相关。
期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-022-30615-x
Damsky, William; Wang, Alice; Kim, Daniel J; Young, Bryan D; Singh, Katelyn; Murphy, Michael J; Daccache, Joseph; Clark, Abigale; Ayasun, Ruveyda; Ryu, Changwan; McGeary, Meaghan K; Odell, Ian D; Fazzone-Chettiar, Ramesh; Pucar, Darko; Homer, Robert; Gulati, Mridu; Miller, Edward J; Bosenberg, Marcus; Flavell, Richard A; King, Brett